Tanya Mezhebovsky is currently the Head of Pharmaceutical Development at Alexion Pharmaceuticals. She holds M.Sc. in Physical Chemistry from Moscow State University after M.V. Lomonosov, Ph.D. in Biophysical Chemistry from the Russian Academy of Sciences, and ALM in Biotechnology from Harvard University. Dr. Mezhebovsky has over 15 years of experience in biotherapeutics pharmaceutical and analytical development, as well as protein characterization. She has a broad expertise in protein formulation development, from pre-formulation to support of commercial products, having worked with monoclonal antibodies, ERT products, hormones, bispecifics, fusion proteins, PEGylated proteins. Dr. Mezhebovsky also has experience with biotherapeutics drug delivery and development of combination products. She has significant expertise in liquid formulation development and optimization of freeze thaw stability of biologics.